Answers are grounded in this paper and cite their sources.
Transgenic rat model uncovers characteristics of CD4+ and CD8+ regulatory T cells, suggesting new research avenues.
Background CD4 + and CD8 + regulatory T cells (Treg) in diverse species include different subsets from different origins. In all species, CD8 + Treg have been poorly characterized. CD4 + and CD8 + Treg in rats have only partially been characterized and there is no rat model in which FOXP3 + Treg are genetically tagged. Results We generated a rat transgenic line using the CRISPR/Cas9 system in which EGFP was inserted in frame on the 3’ end of the Foxp3 gene using a 2A self-cleaving peptide. EGFP was exclusively expressed by CD4 + and CD8 + T cells in similar proportion as observed with anti-FOXP3 antibodies. CD4 + EGFP + Treg were 5-10 times more frequent than CD8 + EGFP + Treg. CD4 + and CD8 + EGFP + Treg expressed both the CD25 high CD127 low CD45RC low/- markers. The suppressive activity of CD4 + and CD8 + Treg was largely confined to EGFP + cells. RNAseq analyses showed similarities but also differences among CD4 + and CD8 + EGFP + cells and provided the first description of the natural FOXP3 + CD8 + Treg transcriptome. In vitro culture of CD4 + and CD8 + EGFP - cells with TGFbeta and IL-2 resulted in the induction of EGFP + Treg. Preferential expansion of CD4 + and CD8 + EGFP + Treg could be detected upon in vivo administration of a low dose of IL-2. Conclusions This new and unique Foxp3-EGFP rat line constitutes a useful model to identify and isolate viable natural and induced CD4 + and CD8 + Treg. Additionally, it allows to identify new molecules expressed in CD8 + Treg that may allow to better define their phenotype and function not only in rats but also in other species.
No takes yet. Share an insight, caveat, or question.
Ménoret et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: